UNSW will lead Australia’s first medical cannabis trial to assess whether cannabis products can enhance the quality of life for adults with terminal cancer in the final stages of their life.
Electroconvulsive therapy remains one of the most effective treatments for severe depression, but new UNSW research shows the gentler ultra-brief pulse stimulation can be just as effective.
UNSW researchers have uncovered a new biomarker for schizophrenia that provides further insight into the development of the debilitating disease and may ultimately improve diagnosis and treatment.
The overwhelming sense of feeling ‘different’ is familiar to many of the 230,000 Australians living with autism. But how does that actually play out as an adult in day-to-day life?
People aren’t productive at work when they’re ill and they risk infecting others, writes Michael Tam.
After testing 70 different drugs over 10 years, Australian cancer researchers have discovered a new drug that holds great promise for treating children with an aggressive form of leukaemia.
Health-care resources are wasted when doctors overuse diagnostic tests, writes Rakesh Kumar.
If health equality for Aboriginal and Torres Strait Islander people is to be achieved, Australia must continue to focus on increasing the numbers of Indigenous doctors, nurses and allied health professionals, writes Peter Smith and Tammy Kimpton.
Environmental chemical exposure is a valid concern, but the evidence does not support hyperbolic claims that we are swimming in a soup of cancer-causing chemicals, writes Darren Saunders.
The government's contention that employment is positive for those with mental illness is strongly supported by the evidence, write Philip Mitchell and Geoffrey Waghorn.